Next-Generation Sequencing (NGS) Market 2022: Size, Share, Trends, Analysis and Forecast to 2027

According to IMARC Group's latest report, titled "Next-Generation Sequencing (NGS) Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global next-generation sequencing (NGS) market reached a value of US$ 13.82 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 40.25 Billion by 2027, exhibiting at a CAGR of 19.5% during 2022-2027.

Next-generation sequencing (NGS) refers to deoxyribonucleic acid (DNA) sequencing methods that aid in genomic discoveries. It involves single-molecule real-time (SMRT), nanopore, ion semiconductor, and sequencing by synthesis (SBS) as common practices. NGS offers enhanced scalability, ultra-high throughput, and accurate outcomes with better precision from low sample inputs. On account of these properties, it is extensively used by pharmaceutical companies, clinics, and research institutions to formulate personalized and genetic medicines.

COVID-19 Impact:

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Download Free Sample Report: https://www.imarcgroup.com/next-generation-sequencing-market/requestsample

Market Trends:

One of the prime factors currently driving the global next-generation sequencing market growth is the increasing prevalence of various chronic ailments, especially amongst the geriatric population. This is further supported by the rising clinical trials and the need for cost-effective medicines for treatment purposes. Additionally, extensive investments being made by pharmaceutical companies to develop novel drugs and vaccines have supplemented the product demand across the globe, thus supporting the market growth. Apart from this, significant improvements in the healthcare infrastructure, the introduction of cloud-based NGS instruments to perform DNA synthesis, and continuous research and development (R&D) activities to develop biomarkers are contributing to the market growth.

Next-Generation Sequencing (NGS) Market 2022-2027 Competitive Analysis and Segmentation:

Competitive Landscape With Key Players:

The competitive landscape of the next-generation sequencing market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

Agilent Technologies
Becton Dickinson and Company
10x Genomics
BGI Group
Eurofins Scientific
F. Hoffmann-La Roche AG
Illumina Inc.
Genewiz, Macrogen
Oxford Nanopore Technologies
Pacific Biosciences
PerkinElmer
Thermo Fisher Scientific
Qiagen N.V.
GenapSys Inc.

Key Market Segmentation:

The report has segmented the global next-generation sequencing market on the basis of sequencing type, product type, technology, application, end-user and region.

Breakup by Sequencing Type:

Whole Genome Sequencing
Targeted Resequencing
Whole Exome Sequencing
RNA Sequencing
CHIP Sequencing
De Novo Sequencing
Methyl Sequencing
Others

Breakup by Product Type:

Instruments
Reagents and Consumables
Software and Services

Breakup by Technology:

Sequencing by Synthesis
Ion Semiconductor Sequencing
Single-Molecule Real-Time Sequencing
Nanopore Sequencing
Others

Breakup by Application:

Drug Discovery and Personalized Medicine
Genetic Screening
Diagnostics
Agriculture and Animal Research
Others

Breakup by End-User:

Academic Institutes & Research Centers
Hospitals & Clinics
Pharmaceutical & Biotechnology Companies
Others

Breakup by Region:

North America
Asia Pacific
Europe
Latin America
Middle East and Africa

Ask Analyst for Customization and Explore Full Report With TOC & List of Figures: https://www.imarcgroup.com/next-generation-sequencing-market

Key Highlights of the Report:

Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape

If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact US:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800

This release was published on openPR.